Is high dose rate brachytherapy reliable and effective treatment for prostate cancer patients? A review of the literature.

Détails

ID Serval
serval:BIB_C0171FEF9037
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Titre
Is high dose rate brachytherapy reliable and effective treatment for prostate cancer patients? A review of the literature.
Périodique
Critical Reviews in Oncology/hematology
Auteur(s)
De Bari B., Daidone A., Alongi F.
ISSN
1879-0461 (Electronic)
ISSN-L
1040-8428
Statut éditorial
Publié
Date de publication
2015
Peer-reviewed
Oui
Volume
94
Numéro
3
Pages
360-370
Langue
anglais
Notes
Publication types: <Publication Status: ppublis hDocument Type: Review
Résumé
The intrinsic physical and radiobiological characteristics of High Dose Rate Brachytherapy (HDR-BT) are well suited to the treatment of prostate cancer. HDR-BT was initially used as a boost to external beam brachytherapy, but has subsequently been employed as the sole treatment, which is termed HDR monotherapy. This review summarizes the clinical outcomes and toxicity results of the principal studies and discusses the radiobiological basis supporting its use.
Pubmed
Web of science
Création de la notice
20/06/2015 9:06
Dernière modification de la notice
03/03/2018 21:05
Données d'usage